Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
MOR MorphoSys
4.220
+0.010+0.24%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Total revenue
132.03% 95.7M 55.61% 59.44M -12.13% 41.47M -45.19% 179.61M
Operating revenue
132.03% 95.7M 55.61% 59.44M -12.13% 41.47M -45.19% 179.61M
Cost of revenue
8.26% 8.1M 70.71% 17.24M 56.35% 7.89M 250.93% 32.2M
Gross profit
159.76% 87.7M 50.18% 42.2M -20.33% 33.57M -53.72% 147.42M
Operating expense
0.67% 116.9M -2.21% 97.31M 43.52% 101.53M 41.41% 425.04M
Selling and administrative expenses
-24.44% 39.1M -38.32% 36.39M -5.05% 36.48M -3.10% 154.22M
-Selling and marketing expense
-27.41% 23.5M -15.77% 24M -22.29% 21.89M 12.81% 121.54M
-General and administrative expense
-19.48% 15.6M -59.39% 12.38M 42.27% 14.59M -36.43% 32.68M
Research and development costs
20.85% 77.8M 50.41% 60.92M 101.28% 65.05M 59.24% 225.21M
Depreciation amortization depletion
-- -- -- -- -- -- -- 7.48M
-Depreciation and amortization
-- -- -- -- -- -- -- 7.48M
Other operating expenses
-- -- -- -- -- -- -- 38.13M
Operating profit
64.55% -29.2M 22.82% -55.11M -137.62% -67.96M -1,646.52% -277.62M
Net non-operating interest income expense
-33.76% -97.2M -269.97% -178.97M -102.62% -52.26M -1,539.31% -68.31M
Non-operating interest income
-- 70.3M -94.14% 6.17M -24.05% 10.55M -99.21% 723K
Non-operating interest expense
130.50% 167.5M -- 185.15M 58.27% 62.82M -31.59% 65.82M
Total other finance cost
-- -- -- -- -- -- -- 3.21M
Other net income (expense)
232.54% 3.4M -1,086.46% -4.93M -243.71% -2.43M -2,914.92% -245.11M
Gain on sale of security
-- -- -- -- -- -- -- -14.84M
Earnings from equity interest
-- -300K -- -- -- -- -- --
Special income (charges)
126.42% 600K -575.50% -951K -200.00% -89K -32,720.32% -230.4M
-Less:Impairment of capital assets
-- -- -- -- -- -- -- 230.71M
-Write off
-126.42% -600K 575.50% 951K 200.00% 89K -145.01% -316K
Other non- operating income (expenses)
309.27% 3.1M -1,427.09% -3.98M -194.16% -2.34M -98.72% 120K
Income before tax
20.13% -123M -794.80% -239.01M -122.60% -122.65M -2,727.82% -591.05M
Income tax
99.76% -100K -129.79% -4.02M 0 -1.58% -76.59M
Net income
-8.98% -122.9M -1,224.36% -234.99M -202.03% -122.65M -625.55% -514.46M
Net income continuous Operations
-8.98% -122.9M -1,224.36% -234.99M -202.03% -122.65M -625.55% -514.46M
Minority interest income
Net income attributable to the parent company
-8.98% -122.9M -1,224.36% -234.99M -202.03% -122.65M -625.55% -514.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-8.98% -122.9M -1,224.36% -234.99M -202.03% -122.65M -625.55% -514.46M
Basic earnings per share
-9.09% -0.9 -1,175.00% -1.72 -182.68% -0.8975 -611.63% -3.85
Diluted earnings per share
-9.09% -0.9 -1,227.87% -1.72 -182.68% -0.8975 -618.60% -3.8506
Dividend per share
Currency Unit
EUREUREUREUR
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
------Unqualified Opinion

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
MorphoSys AG operates as a commercial-stage biopharmaceutical company. It uses groundbreaking science and technologies to discover, develop, and deliver innovative cancer medicines to patients. The firm also engages in the development and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.
CEO: Mr. Jean-Paul Kress
Market: NASDAQ
Listing Date: 04/19/2018
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist